Market revenue in 2022 | USD 203.2 million |
Market revenue in 2030 | USD 54.3 million |
Growth rate | -15.2% (CAGR from 2022 to 2030) |
Largest segment | Swabs |
Fastest growing segment | Swabs |
Historical data | 2020 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Viral Transport Media, Blood Collection Kits, Other Consumables Products, Swabs |
Key market players worldwide | Becton Dickinson & Co, Thermo Fisher Scientific Inc, Labcorp Holdings Inc, Trinity Biotech PLC ADR, QuidelOrtho Corp, Quest Diagnostics Inc, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 sample collection kits market will help companies and investors design strategic landscapes.
Swabs was the largest segment with a revenue share of 42.72% in 2022. Horizon Databook has segmented the India covid-19 sample collection kits market based on viral transport media, blood collection kits, other consumables products, swabs covering the revenue growth of each sub-segment from 2020 to 2030.
India has been expanding its testing capability for COVID-19. As of 29th May 2020, the number of COVID-19 tests carried out in India crossed 17 million. As per a statement by the Indian Health Minister; the country has reached its daily capacity of 100,000 tests, with 504 laboratories performing the tests throughout the country.
On 8th April 2020, the Supreme Court of India ordered private clinics to offer the tests for free, 145 private laboratories are performing the tests in the country. The Indian Council of Medical Research (ICMR) permitted the use of two types of testing kits that require swabs and blood collection kits.
Such factors are anticipated to increase the demand for testing swabs and blood collection kits in the country. In March 2020, MyLab Discovery was the first Indian company to receive Emergency Use Authorization for its COVID-19 diagnostic kits.
Horizon Databook provides a detailed overview of country-level data and insights on the India covid-19 sample collection kits market , including forecasts for subscribers. This country databook contains high-level insights into India covid-19 sample collection kits market from 2020 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account